Topical Aminoglycosides? Yes. The Case for Using These Agents in Chronic ear Disease

Nunez D.A. , Browning G.G. Risks of developing an otogenic intracranial abscess. J Laryngol Otol 1990; 104: 468–72.

Schuknecht H.F. Ablation therapy in the management of Meniere's disease. Acta Otolaryngol 1957; 132(Suppl): 1–42.

Kaplan D.M. , Hehar S.S. , Bance M.L. , Rutka J.A. Intentional ablation of vestibular function using commercially available topical gentamicin-betamethasone eardrops in patients with Meniere's disease: Further evidence for topical eardrop ototoxicity. Laryngoscope 2002; 112: 689–95.

Marais J. , Rutka J.A. Ototoxicity of topical eardrops. Clin Otolaryngol 1998; 23: 360–7.

Gyde M.C. When the weeping stopped: An otologist views otorrhea and gentamicin. Arch Otolaryngol 1976; 102: 542–6.

Lundy L.B. , Graham M.D. Ototoxicity and ototopical medications: A survey of otolaryngologists. Am J Otol 1993; 14: 141–6.